Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD

Abstract

The GA-map Dysbiosis Test identifies and characterises dysbiosis in IBS and IBD patients, and provides insight into a patient's intestinal microbiota. Evaluating microbiota as a diagnostic strategy may allow monitoring of prescribed treatment regimens and improvement in new therapeutic approaches.